The purpose of this review was to evaluate the efficacy and safety of acupuncture therapies in the treatment of psoriasis vulgaris. Embase, CENTRAL, PubMed, AMED, CINAHL, CNKI, CQVIP, CBM, and Wanfang databases were searched from inceptions to May 2013 for prospective randomized controlled trials evaluating acupuncture therapies for psoriasis vulgaris. No language limitations were applied. Studies were assessed using the Cochrane risk of bias tool. The primary outcome was Psoriasis Area Severity Index (PASI) score. Six studies (involving 522 participants) met the eligibility criteria for this review, and 5 were included in quantitative analysis. Due to the diversity of interventions, comparators and reported outcomes, meta-analysis was not possible. Results from single studies produced conflicting results for the outcomes PASI reduction, lesion reduction (non-PASI), PASI score, and relapse rate. There is some evidence of benefit of acupuncture therapies for the treatment of psoriasis vulgaris. However, the conclusions are limited by the small number of included trials and conflicting results from single studies. More research is needed to clarify the effect of acupuncture therapies for psoriasis vulgaris.

Keywords:
Acupuncture, Acupuncture therapy, Psoriasis, Psoriasis vulgaris, Systematic review, Randomized controlled trial
1.
Menter A, Gottlieb A, Feldman SR, et al.: Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008;58:826-850.
2.
Pathirana D, Ormerod AD, Saiag P, et al.: European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009;23(suppl 2):1-70.
3.
Puig L, Bordas X, Carrascosa JM, et al.: Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology (in Spanish). Actas Dermosifiliogr 2009;100:277-286.
4.
Menter A, Korman NJ, Elmets CA, et al.: Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 2009;60:643-659.
5.
Nast A., Boehncke WH, Mrowietz U, et al.: S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges 2012;10(suppl 2):S1-95.
6.
Al-Suwaidan SN, Feldman SR: Clearance is not a realistic expectation of psoriasis treatment. J Am Acad Dermatol 2000;42(5 Pt 1):796-802.
7.
Naldi L, Svensson A, Diepgen T, et al.: Randomized clinical trials for psoriasis 1977-2000: the EDEN survey. J Invest Dermatol 2003;120:738-741.
8.
World Health Organization Regional Office for the Western Pacific: WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region. Manila, WPRO, 2007.
9.
Wu JN: A short history of acupuncture. J Altern Complement Med 1996;2:19-21.
10.
Barnes PM, Bloom B, Nahin RL: Complementary and alternative medicine use among adults and children: United States, 2007. National Health Statistics Reports 2008;12. www.cdc.gov/nchs/data/nhsr/nhsr012.pdf (accessed March 2, 2015).
11.
Tan EK, Millington GW, Levell NJ: Acupuncture in dermatology: an historical perspective. Int J Dermatol 2009;48:648-652.
12.
Chen CJ, Yu HS: Acupuncture, electrostimulation, and reflex therapy in dermatology. Dermatol Ther 2003;16:87-92.
13.
Baron SE, Goodwin RG, Nicolau N, et al.: Use of complementary medicine among outpatients with dermatologic conditions within Yorkshire and South Wales, United Kingdom. J Am Acad Dermatol 2005;52:589-594.
14.
Ben-Arye E, Ziv M, Frenkel M, et al.: Complementary medicine and psoriasis: linking the patient's outlook with evidence-based medicine. Dermatology 2003;207:302-307.
15.
Chen YF, Chang JS: Complementary and alternative medicine use among patients attending a hospital dermatology clinic in Taiwan. Int J Dermatol 2003;42:616-621.
16.
PLA Chinese Medicine Association Professional Committee of Dermatology: Consensus on integrative medicine diagnosis and treatment of psoriasis vulgaris. Chin J Dermatol Venereol Integr Tradit West Med 2009;5:328.
17.
Cheng L: The clinical efficacy research on resting plaque psoriasis with prick bloodletting (in Chinese). Master thesis, Chengdu University of Traditional Chinese Medicine, 2011.
18.
Jerner B, Skogh M, Vahlquist A: A controlled trial of acupuncture in psoriasis: no convincing effect. Acta Derm Venereol 1997;77:154-156.
19.
Wu J-P, Gu S-Z: Randomized controlled trials for treatment of 30 cases of ordinary psoriasis by acupuncture and moxibustion (in Chinese). Zhen Ci Yan Jiu 2011;36:62-65.
20.
Yin G, Zheng L: Clinical observation in 72 cases of blood-heat type psoriasis patients treated by blood-letting puncture (in Chinese). Xinjiang Journal of Traditional Chinese Medicine 2009;27:13-15.
21.
Yu S: Clinical research in treating psoriasis by point-injection of magnetic blood. International Journal of Clinical Acupuncture 2002;13:239-242.
22.
Wang D, Chen J: Pingyinhu cream point application on CV8 for psoriasis vulgaris. Journal of External Therapy of Traditional Chinese Medicine 1999;8:4.
23.
Maciocia G: The Foundations of Chinese Medicine. Edinburgh, Churchill Livingstone, 1989.
24.
Weiss G, Shemer A, Trau H: The Koebner phenomenon: review of the literature. J Eur Acad Dermatol Venereol 2002;16:241-248.
25.
Kirschbaum JO: Koebner phenomenon following acupuncture. Arch Dermatol 1972;106:767.
26.
Wu JJ, Caperton C: Images in clinical medicine. Psoriasis flare from Koebner's phenomenon after acupuncture. N Engl J Med 2013;368:1635.
27.
Zhu LL, Hong Y, Zhang L, et al.: Needle acupuncture-induced Koebner phenomenon in a psoriatic patient. J Altern Complement Med 2011;17:1097-1098.
28.
Yu RX, Hui Y, Li CR: Koebner phenomenon induced by cupping therapy in a psoriasis patient. Dermatol Online J 2013;19:18575.
29.
Bhosle M, Kulkarni A, Feldman SR, et al.: Quality of life in patients with psoriasis. Health Qual Life Outcomes 2006;4:35.
30.
Krueger G, Koo J, Lebwohl M, et al.: The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001;137:280-284.
31.
Langley RG, Krueger GG, Griffiths CE: Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005;64(suppl 2):p. ii18-23; discussion ii24-5.
32.
Gupta M, Schork NJ, Gupta AK, et al.: Suicidal ideation in psoriasis. Int J Dermatol 1993;32:188-190.
33.
Finlay A, Khan G: Dermatology Quality of Life Index (DLQI): a simple, practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-216.
34.
Finlay A, Kelly S: Psoriasis: an index of disability. Clin Exp Dermatol 1987;12:8-11.
35.
Malizia E, Andreucci G, Paolucci D, et al.: Electroacupuncture and peripheral beta-endorphin and ACTH levels. Lancet 1979;2:535-536.
36.
Lee SC, Yin SJ, Lee ML, et al.: Effects of acupuncture on serum cortisol level and dopamine beta-hydroxylase activity in normal Chinese. Am J Chin Med 1982;1062-1069.
37.
Wu MT, Hsieh JC, Xiong J, et al.: Central nervous pathway for acupuncture stimulation: localization of processing with functional MR imaging of the brain - preliminary experience. Radiology 1999;212:133-141.
38.
Lundeberg T, Bondesson L, Thomas M: Effect of acupuncture on experimentally induced itch. Br J Dermatol 1987;117:771-777.
39.
Pfab F, Hammes M, Bäcker M, et al.: Preventive effect of acupuncture on histamine-induced itch: a blinded, randomized, placebo-controlled, crossover trial. J Allergy Clin Immunol 2005;116:1386-1388.
40.
Ezzo J, Berman B, Hadhazy VA, et al.: Is acupuncture effective for the treatment of chronic pain? A systematic review. Pain 2000;86:217-225.
41.
Schulz K, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412.
42.
Vickers A, Goyal N, Harland R, Rees R: Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 1998;19:159-166.
© 2015 S. Karger GmbH, Freiburg
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.